Objective The goal of this study was to review the current human papillomavirus (HPV)
vaccine program and its outcomes to date in Australia. Methods This was a review of the …

Australia commenced an ongoing school based government funded human
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …

Background Human papilloma virus (HPV) types 6 and 11 account for 90 percent of
anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW …

Studies on the epidemiology and natural history of anal human papillomavirus (HPV)
infection are essential to understand the significance of this virus in the aetiology of anal …

Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Background: Cryotherapy cannot destroy subclinical human papillomavirus‐infected cells of
condylomata acuminata (CA). The topical application of aminolevulinic acid (ALA) results in …

The prevalence of genital warts (GW) and self-reported human papillomavirus (HPV) as well
as disease-related psychosocial impact among male and female patients aged 18–60 years …

Objectives To estimate self-reported human papillomavirus (HPV) disease-related
psychosocial impact among male and female patients in South Korea. Design In this …

In this Review, we describe the recent epidemiology of genital warts and postulate what the
future may hold as a result of the introduction of the quadrivalent human papillomavirus …

Background This study estimated genital warts prevalence, genital-warts-related healthcare
resource use and costs, and self-reported human-papillomavirus-related psychosocial …